FDA placed hold on Fulcrum's sickle cell therapy over hematological malignancy concerns
https://www.fiercebiotech.com/biotech/fda-placed-hold-fulcrums-sickle-cell-therapy-over-hematological-malignancy-concerns
Medical Innovation Exchange @ Copywrite 2021. All Rights Reserved.